Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anlotinib”

481 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 481 results

Large-scale testing (Phase 3)Looking for participantsNCT07678229
What this trial is testing

BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL

Who this might be right for
Extranodal NK/T-cell Lymphoma
Rong Tao 150
Testing effectiveness (Phase 2)UnknownNCT04970914
What this trial is testing

Anlotinib Plus Penpulimab (AK105) for Chemo-refractory Metastatic Colorectal Cancer:ALTER-C003

Who this might be right for
Colorectal Cancer
Peking Union Medical College Hospital 32
Testing effectiveness (Phase 2)UnknownNCT04952493
What this trial is testing

Anlotinib or Penpulimab in Combination With RAI for DTC

Who this might be right for
Thyroid Cancer
Peking Union Medical College Hospital 42
Testing effectiveness (Phase 2)UnknownNCT03825705
What this trial is testing

A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma

Who this might be right for
Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 60
Testing effectiveness (Phase 2)UnknownNCT05659186
What this trial is testing

PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer

Who this might be right for
Thyroid Cancer
West China Hospital 20
Very early researchActive Not RecruitingNCT06853769
What this trial is testing

Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University 48
Testing effectiveness (Phase 2)UnknownNCT05029102
What this trial is testing

TAS-102 and Anlotinib in ≥3 Lines mGC

Who this might be right for
Gastric Cancer
Zhejiang University 45
Testing effectiveness (Phase 2)UnknownNCT05075512
What this trial is testing

The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer

Who this might be right for
Breast Neoplasm Female
Zhejiang Cancer Hospital 40
Testing effectiveness (Phase 2)UnknownNCT05311319
What this trial is testing

HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection

Who this might be right for
Hepatocarcinoma
Fudan University 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT05220267
What this trial is testing

Anlotinib Plus Sintilimab as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma

Who this might be right for
Non Clear Cell Renal Carcinoma
Sun Yat-sen University 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT07142421
What this trial is testing

Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
First Affiliated Hospital of Zhejiang University 35
Testing effectiveness (Phase 2)Study completedNCT01878448
What this trial is testing

A Phase II Study of Anlotinib in STS Patients

Who this might be right for
Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 166
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07307443
What this trial is testing

A Phase II Study of Anlotinib and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Lung Cancer.

Who this might be right for
SMARCA4-Deficient TumorLocally Advanced or Metastatic Lung Cancer
Zhijie Wang 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05007093
What this trial is testing

Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib

Who this might be right for
DTC - Differentiated Thyroid Cancer
Yansong Lin 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06456138
What this trial is testing

Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC

Who this might be right for
KRAS Mutation-Related TumorsAdvanced Lung CancerRefractory Tumor
Shanghai Chest Hospital 60
Post-approval studies (Phase 4)UnknownNCT03890055
What this trial is testing

Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride

Who this might be right for
Small Cell Lung Cancer
Chifeng Municipal Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05193617
What this trial is testing

Penpulimab Combined With GP ± Anlotinib as Neoadjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 104
Testing effectiveness (Phase 2)UnknownNCT05013697
What this trial is testing

TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.

Who this might be right for
Esophageal Neoplasms
Henan Cancer Hospital 48
Testing effectiveness (Phase 2)UnknownNCT03589950
What this trial is testing

Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung NeoplasmsDocetaxelPemetrexed+2 more
The First People's Hospital of Lianyungang 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT07728955
What this trial is testing

A Single-arm, Exploratory Clinical Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Anlotinib and Etoposide as First-line Therapy for Elderly Patients With Small-cell Lung Cancer or Those Who Are Intolerant to Intensive Chemotherapy

Who this might be right for
Small Cell Lung Cancer ( SCLC )
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 64
Next Page